Page 74 - New epidemiological and PSMA-expression based paradigms in salivary gland tumors

72
Chapter 4
23 van Riet J, Krol N, Atmodimedjo P, et al. SNPitty: An Intuitive Web Application for Interactive B-Allele Frequency and Copy Number Visualization of Next-Generation Sequencing Data. J Mol Diagn 2018; 20: 166-176
24 Köbel M, Piskorz A, Lee S, et al. Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma. J Path Clin Res 2016; 2: 247-258
25 Kato S, Elkin S, Schwaederle M, et al. Genomic landscape of salivary gland tumors. Oncotarget 2015; 6: 25631-25645
26 Declercq J, Van Dyck F, Braem C, et al. Salivary gland tumors in transgenic mice with targeted PLAG1 proto-oncogene overexpression. Cancer Res 2005; 65: 4544-4553
27 Cao Y, Liu H, Gao L, et al. Cooperation Between Pten and Smad4 in Murine Salivary Gland Tumor Formation and Progression. Neoplasia 2018; 8: 764-774
28 Mantovani F, Collavin L, Del Sal G. Mutant p53 as a guardian of the cancer cell. Cell Death Differ 2019; 26: 199-212
29 Boettcher S, Miller P, Sharma R, et al. A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies. Science (80- ) 2019; 365: 599-604
30 Tashiro T, Hirokawa M, Harada H, et al. Cell membrane expression of MIB-1 in salivary gland pleomorphic adenoma. Histopathology 2002; 41: 559-561
31 Valstar M, de Ridder M, van den Broek E, et al. Salivary gland pleomorphic adenoma in the Netherlands: A nationwide observational study of primary tumor incidence, malignant transformation, recurrence, and risk factors for recurrence. Oral Oncol 2017; 66: 93-99
32 Hernandez-Prera J, Skálová A, Franchi A, et al. Pleomorphic Adenoma: The Great Mimicker of Malignancy. Histopathol 2020 Epub ahead print DOI:10.1111/his.14322.